skip to content

Market News

Toumaz undertakes trials at hospital in Birmingham

21 April 2015 08:12

Toumaz, a company specialising in low-power, wireless semiconductor technologies for healthcare and digital audio, has announced that SensiumVitals®, its wearable vital signs monitoring system, is to be trialled by the Queen Elizabeth Hospital Birmingham (QEHB), part of the University Hospitals Birmingham NHS Foundation Trust.

SensiumVitals® is a wireless system which takes readings of heart rate, respiration and temperature every two minutes with the data sent wirelessly to clinicians via hospital IT systems.

Anthony Sethill, CEO of Toumaz Group, said: "It is a significant development for us to be deploying SensiumVitals® in one of the UK's leading NHS hospitals.

"Our early trials with other hospitals in the US and the UK have shown that SensiumVitals® improves patient care, shortens hospital stays and reduces healthcare costs."

At 8:12am: (LON:TMZ) Toumaz Holdings Ltd share price was -0.12p at 4.38p

Story provided by StockMarketWire.com

Related Company: TMZ

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

Aberdeen Ediston

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.